T. Dao

发表

Semi-elemental formula or polymeric formula: is there a better choice for enteral nutrition in acute pancreatitis? Randomized comparative study.

Xavier Blaizot, R. Gloro, X. Blaizot, 2006, JPEN. Journal of parenteral and enteral nutrition.

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

S. Chevret, S. Pol, V. Bourcier, 2015 .

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF BENIGN LIVER TUMOURS.

V. de Lédinghen, V. Paradis, J. Calderaro, 2021, Clinics and research in hepatology and gastroenterology.

Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patients.

P. Brissot, D. Guyader, Y. Deugnier, 2000, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease

P. Nahon, N. Ganne-Carrié, J. Nault, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.

V. de Lédinghen, P. Marcellin, D. Thabut, 2019, Gastroenterology.

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

V. de Lédinghen, P. Marcellin, F. Carrat, 2014, Gastroenterology.

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

V. de Lédinghen, P. Marcellin, F. Carrat, 2013, Journal of hepatology.

Nutritional indices in cirrhotic patients.

R. Gloro, I. Ollivier, M. Piquet, 2006, Nutrition.

Increased oro-cecal transit time in grade I or II hepatic encephalopathy.

M. Bouin, C. Vincent, M. Piquet, 2004, Gastroenterologie clinique et biologique.

Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.

V. de Lédinghen, T. Asselah, D. Thabut, 2020, Journal of hepatology.

Combination of Model for End‐Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding

M. Rudler, D. Thabut, N. Ganne-Carrié, 2021, Hepatology.

ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts

V. de Lédinghen, P. Marcellin, S. Chevret, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.

J. Cadranel, I. Ollivier-Hourmand, M. Allaire, 2019, Clinics And Research in Hepatology and Gastroenterology.

Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea.

R. Gloro, P. Rousselot, L. Mosquet, 2005, European journal of gastroenterology & hepatology.

Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin

P. Marquet, A. Tran, C. Trépo, 2016, Therapeutic drug monitoring.

Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients

T. Nguyen, I. Ollivier-Hourmand, M. Allaire, 2020, BMC Infectious Diseases.

Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment.

V. de Lédinghen, P. Couzigou, P. Marcellin, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Early nutritional management in non-critically ill coronavirus disease 2019 patients

B. Dupont, C. Dupont, M. Piquet, 2020, Nutrition.

Infectious endocarditis in the case of cirrhosis: where do we stand?

J. Cadranel, I. Ollivier-Hourmand, M. Allaire, 2018, European journal of gastroenterology & hepatology.

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.

M. Ziol, V. de Lédinghen, P. Marcellin, 2017, Gastroenterology.

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients

M. Ziol, V. de Lédinghen, P. Marcellin, 2018, American heart journal.

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case–control study

X. Causse, J. Dumortier, L. Spahr, 2018, European journal of gastroenterology & hepatology.

Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.

V. de Lédinghen, D. Thabut, C. Bureau, 2017, Journal of clinical gastroenterology.

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)

P. Marcellin, F. Roudot-thoraval, F. Zoulim, 2016, Hepatology.

Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families.

J. Zucman‐Rossi, C. Bellanné-Chantelot, Y. Reznik, 2004, The Journal of clinical endocrinology and metabolism.

the Young (MODY)3 Families Liver Adenomatosis and Diabetes Phenotypes in Two Maturity-Onset Diabetes of Hepatocyte Nuclear Factor-1{alpha} Gene Inactivation: Cosegregation between

J. Zucman‐Rossi, C. Bellanné-Chantelot, Y. Reznik, 2004 .

Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit.

B. Dupont, M. Koné, D. Du Cheyron, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prevalence of intestinal parasite among patients attending two hospitals in French Guiana: A 6-year retrospective study

M. Demar, D. Louvel, J. Carod, 2021, PLoS neglected tropical diseases.

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.

V. de Lédinghen, S. Imbeaud, J. Zucman‐Rossi, 2018, Gastroenterology.

Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis.

T. Dao, N. Bouvard, 1991, Gastroenterology.

The epidemiology of Budd-Chiari syndrome in France.

V. de Lédinghen, O. Farges, D. Valla, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma

V. Mazzaferro, M. Teufel, J. Llovet, 2018, Clinical Cancer Research.

Acute alcoholic hepatitis: management in 2011

B. Dupont, M. Piquet, T. Dao, 2011 .

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.

Albert Tran, Vincent Leroy, Dominique Larrey, 2018, Gastroenterology.

Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.

V. de Lédinghen, S. Chevret, S. Pol, 2018, Journal of hepatology.

Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis.

M. Ziol, V. de Lédinghen, J. Zucman‐Rossi, 2022, Journal of hepatology.

Cardiac sources of embolism should be routinely screened in ischemic colitis

E. Saloux, M. Bouin, P. Rousselot, 2003, American Journal of Gastroenterology.

Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.

D. Thabut, A. Duhamel, J. Salleron, 2013, JAMA.

Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)

V. de Lédinghen, P. Marcellin, F. Roudot-thoraval, 2015, Gut.

Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.

S. Chevret, S. Pol, V. Bourcier, 2022, Journal of hepatology.

Subclinical encephalopathy after conscious sedation with midazolam in cirrhotic patients

T. Dao, I. Hourmand-Ollivier, 2003 .

Subclinical Encephalopathy After Conscious Sedation With Midazolam in Cirrhotic Patients??

T. Dao, I. Hourmand-Ollivier, 2003, American Journal of Gastroenterology.

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC.

J. Pignon, M. Ducreux, F. Gay, 1998, Journal of hepatology.

Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication

V. de Lédinghen, P. Marcellin, E. Letouzé, 2018, Hepatology.

[Value of hepatic angioscintigraphy combined to pulsed Echo-Doppler: application to the study of portal hypertension of cirrhotic patients. Apropos of 148 cases].

T. Dao, Y. Fernández, G. Bouvard, 1991, Annales de radiologie.

Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial.

V. de Lédinghen, R. Amathieu, M. Rudler, 2015, Journal of hepatology.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)

V. de Lédinghen, P. Marcellin, S. Chevret, 2015, Hepatology.

Transient hepatofugal portal blood flow in alcoholic cirrhosis with acute alcoholic hepatitis.

M. Piquet, T. Dao, Å. Valla, 1994, Journal of hepatology.

Reply to "Comment on "Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit" by Benoît Dupont et al. [Digestive Liver Disease 2015;47:675-81]".

B. Dupont, T. Dao, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance

V. de Lédinghen, T. Asselah, D. Thabut, 2021, JHEP Reports.

Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy

Xavier Forns, V. de Lédinghen, X. Forns, 2012, PloS one.

[Occlusive syndrome revealing Varicella-zoster virus infection of the digestive system].

D. Arsène, C. Verwaerde, M. Piquet, 1995, Gastroenterologie clinique et biologique.

Management of gastric varices: a French national survey

M. Rudler, D. Thabut, C. Bureau, 2016, European journal of gastroenterology & hepatology.

Early administration of vapreotide for variceal bleeding in patients with cirrhosis.

D. Valla, F. Durand, F. Saliba, 2001, The New England journal of medicine.

CHRONIC ACTIVE HEPATITIS PROGRESSING TO CIRRHOSIS AFTER GERMANDER ADMINISTRATION GASTROENTEROL

T. Dao, Å. Valla, A. Peytier, 1993 .